GC
General Catalyst Group Management, LLC
Sector-focusedContrarianConcentrated strategy
Total reported value
$183.6M
Reporting period: 2026-03-31 · Number of holdings: 12
General Catalyst Group Management, LLC disclosed 12 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $183.6M and a quarterly turnover rate of 28.8%.
Personality snowflake
- Concentration
- 86.49
- Portfolio Stability
- 28.78
- Momentum/Contrarian
- 0
- Sector conviction
- 100
- Diversification
- 24
- Sizing Uniformity
- 86.81
Recent moves
Add AVBP
0.0% $4.4M
Trim GTLB
0.0% -$14.6M
Trim GUTS
0.0% -$8.5M
Add IOT
0.0% -$7.5M
Trim MAZE
0.0% -$12.0M
Add CART
0.0% -$5.3M
Holdings Map
New buyAddUnchangedTrim
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | IOT | Samsara Inc-cl A | Stock-Tech | 34.53% | +2.56% | — | |
| 2 | AVBP | Arrivent Biopharma INC | Stock-Other | 18.79% | +5.23% | — | |
| 3 | MAZE | Maze Therapeutics INC | Stock-Other | 16.85% | -2.50% | — | |
| 4 | CART | Maplebear INC | Stock-Consumer Disc | 14.50% | +0.08% | — | |
| 5 | GTLB | Gitlab Inc-cl A | Stock-Tech | 10.86% | -4.73% | — | |
| 6 | EIKN | Eikon Therapeutics INC | Stock-Other | 1.76% | +1.76% | NEW | |
| 7 | GUTS | Fractyl Health INC | Stock-Other | 1.22% | -3.63% | — | |
| 8 | LIFE | Ethos Technologies INC Cl-a | Stock-Other | 0.45% | +0.45% | NEW | |
| 9 | CPNG | Coupang INC | Stock-Consumer Disc | 0.38% | +0.38% | NEW | |
| 10 | AMZN | Amazon.com INC | Stock-Consumer Disc | 0.29% | +0.29% | NEW | |
| 11 | META | Meta Platforms Inc-class A | Stock-Comm Services | 0.21% | +0.21% | NEW | |
| 12 | FIG | Figma Inc-cl A | Stock-Other | 0.17% | -0.08% | — |
Reported value over time
Sector allocation
Sector allocation over time
Quarterly history
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 12 | $183.6M | 29 | |
| 2025-12-31 | 7 | $221.7M | 100 | |
| 2025-09-30 | 8 | $3.0B | 82 | |
| 2025-06-30 | 10 | $4.3B | 0 | |
| 2025-03-31 | 11 | $887.5M | 100 | |
| 2024-12-31 | 11 | $1.1B | 0 | |
| 2024-09-30 | 11 | $1.4B | 0 | |
| 2024-06-30 | 11 | $1.2B | 0 | |
| 2024-03-31 | 11 | $1.3B | 0 | |
| 2023-12-31 | 10 | $1.3B | 0 | |
| 2023-09-30 | 11 | $1.1B | 0 | |
| 2023-06-30 | 10 | $1.2B | 0 | |
| 2023-03-31 | 10 | $965.0M | 0 | |
| 2022-12-31 | 12 | $889.0M | 0 | |
| 2022-09-30 | 15 | $1.1B | 0 | |
| 2022-06-30 | 15 | $1.1B | 0 | |
| 2022-03-31 | 15 | $1.8B | 0 | |
| 2021-12-31 | 13 | $2.6B | 0 | |
| 2021-09-30 | 12 | $2.0B | 0 | |
| 2021-06-30 | 10 | $2.3B | 29 | |
| 2021-03-31 | 7 | $2.6B | 45 | |
| 2020-12-31 | 5 | $2.9B | 100 | |
| 2018-09-30 | 2 | $28.6M | 19 | |
| 2018-06-30 | 2 | $34.3M | 100 | |
| 2018-03-31 | 1 | $12.6M | 7 | |
| 2017-12-31 | 1 | $13.5M | 0 |
Holding changes this quarter
General Catalyst Group Management, LLC's most significant position changes for 2026-03-31: New buy: Eikon Therapeutics INC (EIKN); New buy: Ethos Technologies INC Cl-a (LIFE); New buy: Coupang INC (CPNG); New buy: Amazon.com INC (AMZN); New buy: Meta Platforms Inc-class A (META).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | AVBP | Arrivent Biopharma INC | +5.2% | — | Unchanged |
| 2 | IOT | Samsara Inc-cl A | +2.6% | — | Unchanged |
| 3 | CART | Maplebear INC | +0.1% | — | Unchanged |
| 4 | FIG | Figma Inc-cl A | -0.1% | — | Unchanged |
| 5 | MAZE | Maze Therapeutics INC | -2.5% | — | Unchanged |
| 6 | GUTS | Fractyl Health INC | -3.6% | — | Unchanged |
| 7 | GTLB | Gitlab Inc-cl A | -4.7% | — | Unchanged |
| 8 | EIKN | Eikon Therapeutics INC | — | NEW | New buy |
| 9 | LIFE | Ethos Technologies INC Cl-a | — | NEW | New buy |
| 10 | CPNG | Coupang INC | — | NEW | New buy |
| 11 | AMZN | Amazon.com INC | — | NEW | New buy |
| 12 | META | Meta Platforms Inc-class A | — | NEW | New buy |
FAQ
What is General Catalyst Group Management, LLC and what type of investor is it?
General Catalyst Group Management, LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately $183.6M, spread across 12 disclosed positions.
What are General Catalyst Group Management, LLC's largest equity positions?
Based on the latest 13F filing, General Catalyst Group Management, LLC's top holdings by market value are:
1. Samsara Inc-cl A (IOT) — $63.4M (34.5%)
2. Arrivent Biopharma INC (AVBP) — $34.5M (18.8%)
3. Maze Therapeutics INC (MAZE) — $30.9M (16.9%)
4. Maplebear INC (CART) — $26.6M (14.5%)
5. Gitlab Inc-cl A (GTLB) — $19.9M (10.9%)
What changes did General Catalyst Group Management, LLC make in its most recent portfolio filing?
In the latest quarter, General Catalyst Group Management, LLC was primarily adding exposure — initiating 5 new positions and adding to 0 existing holdings. The largest of these moves: New buy: Eikon Therapeutics INC (EIKN); New buy: Ethos Technologies INC Cl-a (LIFE); New buy: Coupang INC (CPNG); New buy: Amazon.com INC (AMZN); New buy: Meta Platforms Inc-class A (META)
What sectors does General Catalyst Group Management, LLC focus on?
General Catalyst Group Management, LLC is concentrated in the following sectors based on its current disclosed equity portfolio:
• Information Technology: 74.7%
• Consumer Discretionary: 25.0%
• Communication Services: 0.3%